179033-68-2

Usage

Uses

Used in Pharmaceutical Production:
BOC-L-MEPHE(4-CL)-OH is used as an intermediate in the synthesis of various pharmaceuticals. Its role in peptide synthesis allows for the development of new drugs with specific therapeutic properties.
Used in Cosmetics Industry:
In the cosmetics sector, BOC-L-MEPHE(4-CL)-OH is used as a component in the formulation of various cosmetic products. Its presence may contribute to the development of innovative cosmetic ingredients with improved efficacy and safety.
Used in Agricultural Products:
BOC-L-MEPHE(4-CL)-OH finds application in the agricultural industry, potentially serving as a component in the development of new agrochemicals or as a building block for the synthesis of bioactive compounds used in crop protection and enhancement.
Used in Research and Development:
BOC-L-MEPHE(4-CL)-OH is also utilized in research and development settings, where it can be employed to study the properties of new drug candidates and materials, contributing to scientific advancements in various fields.

Upstream product

• 57292-44-1 N-Boc-D-(4-Cl)Phe-OH 
• 74-88-4 methyl iodide 
• 51301-86-1 Boc-p-chloro-L-Phe-OH 

Relevant academic research and scientific papers

CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS

The disclosure relates to inhibitors of PCSK9 useful in the treatment of cholesterol lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, N-oxide, or tautomer thereof, wherein R1, R1, R1, R1, R1, R1, R1, R1, R1, X1, X2, and X3 are described herein.

Process for production of optically active n-protected-n-methyl-phenylalanine derivative

There is provided a process for industrially and efficiently producing an optically active N-protected-N-methyl-4-halogenophenylalanine at a high purity, which is useful as an intermediate for the production of pharmaceutical agents. An optically active N-protected-N-methyl-4-halogenophenylalanine (including the free form and/or the salt form thereof) purified to a high purity is produced by way of the deposition and isolation in the form of salt (DCHA salt or the like) from an optically active N-protected-N-methyl-4-halogenophenylalanine containing at least the optical isomer thereof as an impurity. Because the intended compound at a high purity can be recovered and obtained at a high yield, the process of the present invention is very useful as a process for producing the intermediate for the production of pharmaceutical agents.